Platelets and Coronary Artery Disease

  • Meinrad GawazEmail author
  • Harald Langer
  • Tobias Geisler


Platelets play a critical role in thrombosis and hemostasis [1, 2]. Beyond that, platelets have been recognized to act as an interface between thrombosis and inflammation [3]. Previous research has shown that inflammation plays a key role in the development of coronary artery disease (CAD) and other manifestations of atherosclerosis [4]. Recently, platelets have been recognized to trigger atherosclerotic lesion formation, to favor plaque instability, and to form thrombosis at areas of vulnerable plaques, resulting in myocardial infarction and tissue ischemia. During atherogenesis platelets interact with a variety of vascular and blood-borne cells (e.g., endothelial cells and leukocytes) and regulate chemotaxis, migration, and cytokine/chemokine release, which further propagate inflammation within vascular lesions [3, 5]. Understanding the role of platelets in atherogenesis will allow developing new strategies in the treatment of coronary artery disease.


Platelet Adhesion Adherent Platelet Atherosclerotic Lesion Formation Circulate Progenitor Cell Endothelial Denudation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors were supported in part by the Deutsche Forschungsgemeinschaft and the Klinische Forschergruppe KFO-274 “Platelets-Molecular Mechanisms and Translational Implications”.


  1. 1.
    Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–94.PubMedCrossRefGoogle Scholar
  2. 2.
    Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227–34.PubMedCrossRefGoogle Scholar
  3. 3.
    Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115:3378–84.PubMedCrossRefGoogle Scholar
  4. 4.
    Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.PubMedCrossRefGoogle Scholar
  5. 5.
    May AE, Seizer P, Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol. 2008;28:S5–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med. 1998;187:329–39.PubMedCrossRefGoogle Scholar
  7. 7.
    Gawaz M, Neumann FJ, Dickfeld T, Reininger A, Adelsberger H, Gebhardt A, et al. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation. 1997;96:1809–18.PubMedCrossRefGoogle Scholar
  8. 8.
    Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res. 2004;61:498–511.PubMedCrossRefGoogle Scholar
  9. 9.
    Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 1991;174:785–90.PubMedCrossRefGoogle Scholar
  10. 10.
    Gawaz M, Neumann FJ, Dickfeld T, Koch W, Laugwitz KL, Adelsberger H, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation. 1998;98:1164–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Gawaz M, Page S, Massberg S, Nothdurfter C, Weber M, Fisher C, et al. Transient platelet interaction induces MCP-1 production by endothelial cells via I kappa B kinase complex activation. Thromb Haemost. 2002;88:307–14.PubMedGoogle Scholar
  12. 12.
    Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis. 2000;148:75–85.PubMedCrossRefGoogle Scholar
  13. 13.
    von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 2001;103:1772–7.CrossRefGoogle Scholar
  14. 14.
    Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591–4.PubMedCrossRefGoogle Scholar
  15. 15.
    May AE, Kalsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation. 2002;106:2111–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301–14.PubMedCrossRefGoogle Scholar
  17. 17.
    Gardiner EE, De Luca M, McNally T, Michelson AD, Andrews RK, Berndt MC. Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G. Blood. 2001;98:1440–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Diacovo TG, DeFougerolles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2. J Clin Invest. 1994;94:1243–51.PubMedCrossRefGoogle Scholar
  19. 19.
    Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood. 1996;88:146–57.PubMedGoogle Scholar
  20. 20.
    Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002;196:679–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res. 2006;98:E2–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006;203:1221–33.PubMedCrossRefGoogle Scholar
  23. 23.
    Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation. 2008;117:206–15.PubMedCrossRefGoogle Scholar
  24. 24.
    de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, Biessen EA, et al. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol. 2006;26:1653–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4(+) hemangiocytes. Nat Med. 2006;12:557–67.PubMedCrossRefGoogle Scholar
  26. 26.
    Daub K, Langer H, Seizer P, Stellos K, May AE, Goyal P, et al. Platelets induce differentiation of human CD34(+) progenitor cells into foam cells and endothelial cells. FASEB J. 2006;20:2559.PubMedCrossRefGoogle Scholar
  27. 27.
    Lev EI, Patel R, Karim A, Kleiman A, Badimon JJ, Kleiman NS. Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study. Thromb Haemost. 2006;95:441–6.PubMedGoogle Scholar
  28. 28.
    Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887–96.PubMedCrossRefGoogle Scholar
  29. 29.
    Bultmann A, Li ZM, Wagner S, Peluso M, Schonberger T, Weis C, et al. Impact of glycoprotein VI and platelet adhesion on atherosclerosis-A possible role of fibronectin. J Mol Cell Cardiol. 2010;49:532–42.PubMedCrossRefGoogle Scholar
  30. 30.
    Schonberger T, Siegel-Axel D, Bussl R, Richter S, Judenhofer MS, Haubner R, et al. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE−/− mice. Cardiovasc Res. 2008;80:131–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Ungerer M, Rosport K, Bultmann A, Piechatzek R, Uhland K, Schlieper P, et al. Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation. 2011;123:1891–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Department of CardiologyUniversity of TübingenTübingenGermany

Personalised recommendations